Loading...
research article
Treatment of Tuberculosis with Rifamycin-containing Regimens in Immune-deficient Mice
Rationale: Daily rifapentine plus isoniazid-pyrazinamide in mice infected with Mycobacterium tuberculosis produces cure in 3 months. Whether cure corresponds to latent infection contained by host immunity or true tissue sterilization is unknown.
Type
research article
Web of Science ID
WOS:000290005100022
Authors
•
Li, Si-Yang
•
Rosenthal, Ian M.
•
Almeida, Deepak V.
•
Ahmad, Zahoor
•
Converse, Paul J.
•
Peloquin, Charles A.
•
Nuermberger, Eric L.
•
Grosset, Jacques H.
Publication date
2011
Volume
183
Start page
1254
End page
1261
Peer reviewed
REVIEWED
EPFL units
Available on Infoscience
December 16, 2011
Use this identifier to reference this record